<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF06ABFB-9547-484C-84F9-4110ED8759B7"><gtr:id>BF06ABFB-9547-484C-84F9-4110ED8759B7</gtr:id><gtr:name>Manchester University NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Central Manchester University Hospitals NHS Foundation Trust,Manchester Royal Infirmary,Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1CC23DC2-3991-4123-B5F2-83C1F5793403"><gtr:id>1CC23DC2-3991-4123-B5F2-83C1F5793403</gtr:id><gtr:name>F. Hoffmann-La Roche AG</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF06ABFB-9547-484C-84F9-4110ED8759B7"><gtr:id>BF06ABFB-9547-484C-84F9-4110ED8759B7</gtr:id><gtr:name>Manchester University NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Central Manchester University Hospitals NHS Foundation Trust,Manchester Royal Infirmary,Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1CC23DC2-3991-4123-B5F2-83C1F5793403"><gtr:id>1CC23DC2-3991-4123-B5F2-83C1F5793403</gtr:id><gtr:name>F. Hoffmann-La Roche AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5BDDACE4-A286-48AB-B59C-9219CC4C484D"><gtr:id>5BDDACE4-A286-48AB-B59C-9219CC4C484D</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>S</gtr:otherNames><gtr:surname>Stevenson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9CF3D997-EE83-49A2-8AEA-28F2259C6D0A"><gtr:id>9CF3D997-EE83-49A2-8AEA-28F2259C6D0A</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Birrell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800196"><gtr:id>10620768-E8E9-45EB-86FE-2552C02B996F</gtr:id><gtr:title>IKK-2 inhibition: A novel approach for treating steroid-resistant lung inflammation precipitated by cigarette smoking?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800196</gtr:grantReference><gtr:abstractText>Chronic obstructive pulmonary disease is an inflammatory disease of the lung that affects a large percentage of the population around the world and represents a huge health care burden. It is characterised by breathing difficulties (e.g. shortness of breath) that progressively worsens with age and is associated with a history of smoking cigarettes. It is believed that there are currently 600 million people living with the disease worldwide and every hour COPD is estimated to kill 250 people. COPD has now become a greater drain on health resources than asthma, and exceeds the healthcare spending on asthma by some three-fold in industrialised countries. These costs will escalate further as the prevalence of COPD is predicted to increase throughout the world over the next 20 yrs. In the UK COPD now causes about 30,000 deaths a year and mortality is almost double the European average, with COPD killing more women than breast cancer last year. Unfortunately, there are no treatments for patients that can slow the progressive nature of the disease. Inflammation is believed to be central to the development and symptoms of COPD. There is an enzyme in cells that is involved in controlling the level of inflammation in the lung. Blocking the function of this enzyme may reduce the inflammation and slow the progression of the disease. The aim of this study is to try to determine whether blocking this enzyme?s function will reduce lung inflammation associated with COPD. The hope is that this work may lead to the discovery of a novel drug which could selectively target this enzyme leading to a useful therapy that could help these patients who suffer from this debilitating disease.</gtr:abstractText><gtr:technicalSummary>Chronic obstructive pulmonary disease (COPD) is a smoking-related lung disease characterised by airway inflammation and airflow obstruction that kills 250 people every hour around the world. The chronic inflammation is believed to cause structural changes to the lung that lead to reduced lung function, disability and death. The inflammation is largely steroid-insensitive and currently, no therapies are available to reduce the inflammation or delay disease progression. Steroids work principally by inhibiting the activation of NF-kB, a transcription factor that controls pro-inflammatory gene expression. In COPD patients, it is believed that there are modifications in the steroid receptor complex that reduces its ability to repress NF-kB function. Thus, alternative strategies aimed at inhibiting NF-kB activation may abrogate the inflammation associated with COPD. One approach is to inhibit IKK-2, a kinase that is involved in the release of NF-kB from its inhibitor complex in the cytoplasm. This allows NF-kB to translocate to the nucleus and trigger gene expression. Our current proposal aims to assess whether IKK-2 inhibition can attenuate cigarette smoking-related lung inflammation. First, we intend to develop models of cigarette smoke-induced (steroid-insensitive) inflammation in mice. Next, we plan to test IKK-2 small molecule inhibitors, IKK-2 conditional knockout mice and siRNA oligonucleotides directed against IKK-2 in these animal models and assess the changes in inflammation. Finally, we aim to translate these findings by examining these same tool inhibitors in human cell models related to COPD inflammation, including using inflammatory cells isolated directly from the lungs COPD patients. This work would result in us developing what is considered to be the most relevant animal model for COPD (unique among UK academic groups) and may highlight IKK-2 inhibition as a novel approach for the treatment of COPD.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>565046</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Link between chronic respiratory disease and cardiovascular complications</gtr:description><gtr:id>A5757C57-88E2-40B4-9657-D75FF6D40501</gtr:id><gtr:impact>Abstracts will be submitted and grants to fund future work are in preparation</gtr:impact><gtr:outcomeId>545a3dabe50ef7.78043826-1</gtr:outcomeId><gtr:partnerContribution>Experiments to evaluate cardiovascular danger signals in our models</gtr:partnerContribution><gtr:piContribution>We have provided samples from our lung disease smoke exposure models to our collaborators for them to look at disease relevant biomarkers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>F. Hoffmann-La Roche AG</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Mechanisms involved in smoking-induced inflammation</gtr:description><gtr:id>73ADDADC-96E4-4E34-86EA-5D059851455A</gtr:id><gtr:impact>Abstracts submitted to International Meetings (e.g. American Thoracic Society)</gtr:impact><gtr:outcomeId>on6LusbnzRE-1</gtr:outcomeId><gtr:partnerContribution>Access to pharmacological tools, pharmacokinetic support, molecular tools (gene chips), and bioinformatic support</gtr:partnerContribution><gtr:piContribution>Testing novel hypotheses related to chronic lung diseases using models developed during this porject.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Respiratory Pfizer</gtr:department><gtr:description>IKK-2 conditional knockout mice and proprietary compounds</gtr:description><gtr:id>2228F8A0-A835-4130-9262-DB9AA7AABAFC</gtr:id><gtr:impact>The generation of data which will led to the publication of a manuscript-listed in publication section</gtr:impact><gtr:outcomeId>tpnVoZoaGU6-1</gtr:outcomeId><gtr:partnerContribution>Provision of IKK-2 knockout mice and proprietary compounds</gtr:partnerContribution><gtr:piContribution>Pfizer have provided these mice</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Manchester University NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The role of IL-1beta and IL-18 signalling pathways in disease exacerbations</gtr:description><gtr:id>AB5377E8-4629-41C2-9569-B3ADFF028846</gtr:id><gtr:impact>Clinical sample generation underway.
Multi-disciplinary linking basic science with clinical medicine</gtr:impact><gtr:outcomeId>sceZQKmhWjg-1</gtr:outcomeId><gtr:partnerContribution>We will obtain human clinical samples wich we can use tovalidate our hypothesis genrated in animal models</gtr:partnerContribution><gtr:piContribution>Hypothesis to be tested, preliminary data and sample analyses</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Lung ageing and DNA damage at telomeres</gtr:description><gtr:id>D2B09D82-7CDF-4BA6-8F11-444F85E2CA7B</gtr:id><gtr:impact>Paper under consideration at Thorax</gtr:impact><gtr:outcomeId>545a43f5374d45.64698711-1</gtr:outcomeId><gtr:partnerContribution>Collaborators have assessed ageing dependent biomarkers.
Paper is under consideration at Thorax</gtr:partnerContribution><gtr:piContribution>we provided carefully phenotyped samples from our murine models of smoke exposure to our collaborators</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>HEFCE Medical Sciences summer school held at Imperial College.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E9EF7069-D963-4747-85C1-7CFBF721696C</gtr:id><gtr:impact>Debate with 6th form students.

Good feedback from students and lots of discussion after the activity</gtr:impact><gtr:outcomeId>ThUyXPHMsTo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contribution to an Imperial College outreach event</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>09D993B4-C5FB-4782-B748-3AF106FBD232</gtr:id><gtr:impact>Approximately 60 students attended a science outreach open day. 
Our group led a discussion related to the use of animals in research

Schools noted that the students had enjoyed the trip and that this may influence career decisions to go into a scientific related career in the future.</gtr:impact><gtr:outcomeId>mT1o1RZhapf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imperial College - Non-science students</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FE7866C5-AAF6-4BC0-AEDF-184CBC5EB0AE</gtr:id><gtr:impact>Talk to MSc Science Communication students

Lots of questions and good feedback from participants</gtr:impact><gtr:outcomeId>tUMf2dUn5Ca</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Breathless' event at the Dana Centre.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9BEC87F0-C52C-4356-9F9C-CB86C5D34A46</gtr:id><gtr:impact>Outreach talk regarding the use of animals in medical research.

Very good discussions and feedback from participants</gtr:impact><gtr:outcomeId>SJ4efCgapkJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>South Camden Community School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4BEC3679-ABEA-4FC0-A5FD-178972FAAF6B</gtr:id><gtr:impact>Talk to 6th form students about the use of animals in medical research

Good feedback from the students and instructors</gtr:impact><gtr:outcomeId>Szy3nNVfncU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Kingston</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0F300D31-EC04-4E4A-8A70-7E379389D034</gtr:id><gtr:impact>Presented to students about our work investigating the effects of cigarette smoking on lung health and about the environment in a research laboratory.

We had several discussions with students and staff after the presentation.</gtr:impact><gtr:outcomeId>8F926EEF63C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chelsea Academy Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A9CDD9B1-D25D-4A17-B005-9BC28E44D399</gtr:id><gtr:impact>Talk to 6th form students regarding the use of animals in medical research.

Good discussions and feedback from students and teachers.</gtr:impact><gtr:outcomeId>F9QzCZ6tjFp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Henry Compton School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D4220B34-D25B-4171-88B4-57A654C12CB8</gtr:id><gtr:impact>Two talks to 14-16 year olds regarding the use of animals in medical research.

Good discussions and feedback from the students after the talk.</gtr:impact><gtr:outcomeId>QFeUMG7kfEa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tiffin Girl's School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>39C9DAB9-D828-4362-9B32-076D6D785BB6</gtr:id><gtr:impact>Talk to 6th form students from Tiffin and Tiffin Girl's regarding the use of animals in medical research.

Very good discussions and questions from the students. Good feedback from instructors, too.</gtr:impact><gtr:outcomeId>tU2YF3xVtbf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project grant (Increasing aerobic capacity: A novel approach for treating the inflammatory and physiological damage precipitated by cigarette smoking)</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>088284/Z/09/Z</gtr:fundingRef><gtr:id>132D8EF2-041F-40B0-9449-89C098FEF457</gtr:id><gtr:outcomeId>ED49C8D2D1B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Our work is being used to teach Medical students (BSc), graduate students and professional courses for reseacrhers as well as clinicians</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EF99A40C-0CB0-4645-A6E6-6178D477968F</gtr:id><gtr:impact>Our work has revealed potential molecular mechanisms that regulate the inflammation induced by cigarette smoke exposure. This work has identified potential druggable targets to treat chronic obstructive pulmonary disease.</gtr:impact><gtr:outcomeId>6AA12D41764</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Presentations at National Pharmacology and Respiratory meetings</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>950C3F4B-86DF-40A2-9BA4-36991B638D94</gtr:id><gtr:outcomeId>45F9ABC0F94</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Presentations at International Respiratory and Inflammation Meetings</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6D31DACC-2FDC-4275-ADF7-9D47F2027EAC</gtr:id><gtr:outcomeId>88B4FEAA395</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3A28FC64-5939-446B-8860-C81D91AA3D1D</gtr:id><gtr:title>Do the current house dust mite-driven models really mimic allergic asthma?</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>585d6197bfdec0.40493359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43A01F3B-E58A-4DE5-AE25-E7E534ABEADA</gtr:id><gtr:title>P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97eb9fc76e927a22b29a2331acd7a0d2"><gtr:id>97eb9fc76e927a22b29a2331acd7a0d2</gtr:id><gtr:otherNames>Eltom S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>GXjcWeYjECH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBEB2814-F69F-46BB-A061-88412DD66982</gtr:id><gtr:title>The role of the NLRP3 inflammasome in the pathogenesis of airway disease.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn><gtr:outcomeId>DVnqhJdggoQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B30870BB-6363-4DC4-B250-2EC2E7C8484C</gtr:id><gtr:title>Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5190029ab216c357cc962e19a2158604"><gtr:id>5190029ab216c357cc962e19a2158604</gtr:id><gtr:otherNames>Marwick JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>DgoPWWA4AVW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D05DFA2-7775-4474-BD24-24D2A885670E</gtr:id><gtr:title>Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c33c0ff2311037a74339b2f3f89834bc"><gtr:id>c33c0ff2311037a74339b2f3f89834bc</gtr:id><gtr:otherNames>Shenker NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14404_24_23175441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B785233F-317B-4257-ADDE-FE1AFAFA73EF</gtr:id><gtr:title>Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35898b42e1f13925fdacacb0953f87aa"><gtr:id>35898b42e1f13925fdacacb0953f87aa</gtr:id><gtr:otherNames>Stevenson CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn><gtr:outcomeId>EHSdDP1Acdr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F03452D8-6B20-4F53-B0F0-F2EEF9412A11</gtr:id><gtr:title>Transient receptor potential A1 channels: insights into cough and airway inflammatory disease.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>doi_55f984984a23e38a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>514B79B9-60CB-4668-B88C-583EC5A2813B</gtr:id><gtr:title>TRP channel antagonists as potential antitussives.</gtr:title><gtr:parentPublicationTitle>Lung</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c75c3f5aed9961aead9453022804d3"><gtr:id>e1c75c3f5aed9961aead9453022804d3</gtr:id><gtr:otherNames>Grace MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0341-2040</gtr:issn><gtr:outcomeId>pm_55f94509450ccb04c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>803F4117-0CD3-4712-86F4-165CA73DFD1A</gtr:id><gtr:title>Cigarette smoke induced airway inflammation is independent of NF-?B signalling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4f302798b162e4c15f5946b501b744d"><gtr:id>a4f302798b162e4c15f5946b501b744d</gtr:id><gtr:otherNames>Rastrick JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14404_24_23349803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94050565-47BE-443C-89CC-4E05C2C4ECC7</gtr:id><gtr:title>Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf94e702df2683997992c62be33df36b"><gtr:id>bf94e702df2683997992c62be33df36b</gtr:id><gtr:otherNames>Maher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>doi_55f984984a117f12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C1E00B1-70CD-458D-973A-101195109B88</gtr:id><gtr:title>Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_55f94509450d7b0f2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C20F8C4E-662E-45A2-9B35-7EEC2584511F</gtr:id><gtr:title>House dust mite induces direct airway inflammation in vivo: implications for future disease therapy?</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/988fb4afac3e5fb44a5d0eb4071b22f5"><gtr:id>988fb4afac3e5fb44a5d0eb4071b22f5</gtr:id><gtr:otherNames>De Alba J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>7DE97147FFD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDCDD423-76E0-4144-AC22-0738D1F52952</gtr:id><gtr:title>TRPA1 receptors in cough.</gtr:title><gtr:parentPublicationTitle>Pulmonary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c75c3f5aed9961aead9453022804d3"><gtr:id>e1c75c3f5aed9961aead9453022804d3</gtr:id><gtr:otherNames>Grace MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1094-5539</gtr:issn><gtr:outcomeId>doi_55f9849849e8b5e8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAE398C6-2099-4DE5-9881-94B9B054E0D2</gtr:id><gtr:title>Cigarette smoke exposure as a model of inflammation associated with COPD.</gtr:title><gtr:parentPublicationTitle>Current protocols in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97eb9fc76e927a22b29a2331acd7a0d2"><gtr:id>97eb9fc76e927a22b29a2331acd7a0d2</gtr:id><gtr:otherNames>Eltom S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1934-8282</gtr:issn><gtr:outcomeId>pm_14404_24_23456614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93C9F3B1-21BE-426E-BB89-3DCA5626AC5C</gtr:id><gtr:title>A role for sensory nerves in the late asthmatic response.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b55a51605949dd812ca5f0f589b7cd6a"><gtr:id>b55a51605949dd812ca5f0f589b7cd6a</gtr:id><gtr:otherNames>Raemdonck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>doi_55f9849849f3de66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C5C675B-50D6-4714-9136-E1045B97ADD8</gtr:id><gtr:title>TRPA1 agonists evoke coughing in guinea pig and human volunteers.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>doi_55f984984a1a49b5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>889846BA-5982-4ABC-81A7-FB233D481B3D</gtr:id><gtr:title>Cigarette smoke regulates VEGFR2-mediated survival signaling in rat lungs.</gtr:title><gtr:parentPublicationTitle>Journal of inflammation (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5190029ab216c357cc962e19a2158604"><gtr:id>5190029ab216c357cc962e19a2158604</gtr:id><gtr:otherNames>Marwick JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1476-9255</gtr:issn><gtr:outcomeId>cUkpDkYnjij</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>591A23C5-49B1-4866-BDF4-1923EE1F545C</gtr:id><gtr:title>Harvesting, isolation, and functional assessment of primary vagal ganglia cells.</gtr:title><gtr:parentPublicationTitle>Current protocols in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca7bbf9d2f4641822911b446142a2085"><gtr:id>ca7bbf9d2f4641822911b446142a2085</gtr:id><gtr:otherNames>Dubuis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1934-8282</gtr:issn><gtr:outcomeId>585d5a23391fc9.18306787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD668F73-ED30-49A2-9755-D674FA8A720C</gtr:id><gtr:title>Role of transient receptor potential and pannexin channels in cigarette smoke-triggered ATP release in the lung.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86657e337abedb83adf26de5d8f16dcd"><gtr:id>86657e337abedb83adf26de5d8f16dcd</gtr:id><gtr:otherNames>Baxter M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>545a393fae67a0.65169596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32D2E858-A214-4A2A-B7AC-9920374C614F</gtr:id><gtr:title>Preclinical animal models of asthma and chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Expert review of respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35898b42e1f13925fdacacb0953f87aa"><gtr:id>35898b42e1f13925fdacacb0953f87aa</gtr:id><gtr:otherNames>Stevenson CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1747-6348</gtr:issn><gtr:outcomeId>m2Gq7M2VQbt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0506D3F-9BFB-4A8E-92B4-9AE3017A2259</gtr:id><gtr:title>Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect?</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>585d5a016d3004.16041612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11C05364-E476-4A5A-A44E-82420B228C2B</gtr:id><gtr:title>Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa7aa59a908e8591ff3c3183bd9bad13"><gtr:id>fa7aa59a908e8591ff3c3183bd9bad13</gtr:id><gtr:otherNames>Wan WY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>mSFkDn69hVt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D8D54D1-F132-4453-A1FE-F09E0CABE784</gtr:id><gtr:title>Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8603744bac0fd9c512c0c37ca4382a6a"><gtr:id>8603744bac0fd9c512c0c37ca4382a6a</gtr:id><gtr:otherNames>Edwards MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn><gtr:outcomeId>8C341E9C717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83869825-504B-488A-920D-35130F870590</gtr:id><gtr:title>Cigarette Smoke Exposure Alters mSin3a and Mi-2alpha/beta Expression; implications in the control of pro-inflammatory gene transcription and glucocorticoid function.</gtr:title><gtr:parentPublicationTitle>Journal of inflammation (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5190029ab216c357cc962e19a2158604"><gtr:id>5190029ab216c357cc962e19a2158604</gtr:id><gtr:otherNames>Marwick JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1476-9255</gtr:issn><gtr:outcomeId>QYzrutRTP6z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFE1EFA0-FF72-42F1-BACE-858098705718</gtr:id><gtr:title>The role of the inflammasome in fibrotic respiratory diseases.</gtr:title><gtr:parentPublicationTitle>Minerva medica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4958150fc4d296d81c2edbec8e61e69e"><gtr:id>4958150fc4d296d81c2edbec8e61e69e</gtr:id><gtr:otherNames>Rastrick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0026-4806</gtr:issn><gtr:outcomeId>545a39dc10c275.07944727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1F32F05-B52E-4727-96D4-8B6A5C2A0136</gtr:id><gtr:title>Is intrinsic aerobic exercise capacity a determinant of COPD susceptibility?</gtr:title><gtr:parentPublicationTitle>Pulmonary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35898b42e1f13925fdacacb0953f87aa"><gtr:id>35898b42e1f13925fdacacb0953f87aa</gtr:id><gtr:otherNames>Stevenson CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1094-5539</gtr:issn><gtr:outcomeId>pm_14404_24_23353136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B5BB723-F5A4-4AD2-A4D7-648065A7F96D</gtr:id><gtr:title>MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10228a90ad0aaf5ed5d01ef48feff77b"><gtr:id>10228a90ad0aaf5ed5d01ef48feff77b</gtr:id><gtr:otherNames>Wong S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>pm_14404_14_19650897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A335A22-DF6A-4770-AA72-C2AB1D5FBD74</gtr:id><gtr:title>EP4 receptor as a new target for bronchodilator therapy.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35ed95dd227d373240e59c417dc003ae"><gtr:id>35ed95dd227d373240e59c417dc003ae</gtr:id><gtr:otherNames>Buckley J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>doi_55f984984a06bc49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FCD91B1-5826-4DDC-BED1-DC6728A3085A</gtr:id><gtr:title>Theophylline inhibits the cough reflex through a novel mechanism of action.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca7bbf9d2f4641822911b446142a2085"><gtr:id>ca7bbf9d2f4641822911b446142a2085</gtr:id><gtr:otherNames>Dubuis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>doi_55f9849849df13f9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>712B5107-0268-46AE-AC61-99D76F073A49</gtr:id><gtr:title>Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/409013ced707ef97e89d9fe80edc73a9"><gtr:id>409013ced707ef97e89d9fe80edc73a9</gtr:id><gtr:otherNames>Grace M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>doi_55f9849849fcaca0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800196</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>